Identifying drug safety issues: from research to practice

被引:75
作者
Gandhi, TK
Seger, DL
Bates, DW
机构
[1] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Partners HealthCare Syst, Ctr Appl Med Informat Syst Res, Boston, MA USA
关键词
adverse drug events; drug safety; medication errors; methodology;
D O I
10.1093/intqhc/12.1.69
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose. Adverse drug events (ADEs), or injuries due to drugs, are common and often preventable. However, identifying ADEs, potential ADEs, and medication errors can be a major challenge. In this review we describe methodologies that have been used to identify these events and give strategies for identification in non-study settings. Results. Methods such as voluntary reporting, chart review and computerized monitoring for events have been most commonly used in studies of ADEs in inpatients. However, voluntary reporting, the method most hospitals currently use, has a very low yield of events. Chart review is much more sensitive but the costs are prohibitive. Computerized monitoring for ADEs (using rules or triggers) is a high yield and relatively inexpensive strategy that should be adopted by organizations. A limitation of this strategy, however, is that it identifies few medication errors and potential ADEs, which are also important. These can be captured through pharmacy logs, chart review, and direct observation. Once events have been identified, they can be classified by type of event, severity, and preventability. In non-study settings, the most practical method for identifying ADEs is computerized monitoring, and for identifying prescribing errors it is pharmacy logs of interventions. Once problems are found, a structure (either individual or committee) must be in place to classify them, identify opportunities for improvement, and carry out the necessary changes. Conclusions. Health care organizations have the technology to significantly improve their detection of ADEs, medication errors, and potential ADEs. Identification and subsequent classification of events is crucial for quality efforts to improve patient safety.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 38 条
[1]   FUNDAMENTALS OF MEDICATION ERROR RESEARCH [J].
ALLAN, EL ;
BARKER, KN .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03) :555-571
[2]  
Bates D W, 1998, Jt Comm J Qual Improv, V24, P197
[3]   Medication errors - How common are they and what can be done to prevent them? [J].
Bates, DW .
DRUG SAFETY, 1996, 15 (05) :303-310
[4]   Drugs and adverse drug reactions - How worried should we be? [J].
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1216-1217
[5]   Effect of computerized physician order entry and a team intervention on prevention of serious medication errors [J].
Bates, DW ;
Leape, LL ;
Cullen, DJ ;
Laird, N ;
Petersen, LA ;
Teich, JM ;
Burdick, E ;
Hickey, M ;
Kleefield, S ;
Shea, B ;
Vander Vliet, M ;
Seger, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15) :1311-1316
[6]   RELATIONSHIP BETWEEN MEDICATION ERRORS AND ADVERSE DRUG EVENTS [J].
BATES, DW ;
BOYLE, DL ;
VLIET, MVV ;
SCHNEIDER, J ;
LEAPE, L .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (04) :199-205
[7]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[8]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[9]  
BATES DW, 1999, IN PRESS J AM MED IN
[10]   SENSITIVITY AND SPECIFICITY OF 3 METHODS OF DETECTING ADVERSE DRUG-REACTIONS [J].
BERRY, LL ;
SEGAL, R ;
SHERRIN, TP ;
FUDGE, KA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (07) :1534-1539